1.Acupuncture Treatment for Diarrhea-Predominant Irritable Bowel Syndrome Based on the Theory of "Simultaneous Regulation of Body and Spirit"
Ziyue WU ; Jiping ZHAO ; Sheng CHEN ; Chao YANG
Journal of Traditional Chinese Medicine 2026;67(12):1334-1338
Diarrhea-predominant irritable bowel syndrome (IBS-D) exhibits typical characteristics of psychosomatic comorbidity. Its core pathogenesis is considered to involve simultaneous disorders of both the body and the spirit, for which the former is attributed to liver constraint and spleen deficiency, and dysfunction of large intestine conduction, whereas the latter is induced by spirit restlessness of zang (脏) organs, and gate insecurity of the corporeal soul. Based on this understanding, the therapeutic principle of "simultaneous regulation of body and spirit" is established. For regulating the body, the methods include soothing the liver, fortifying the spleen, consolidating the intestines, and stopping diarrhea, with emphasis on the front-mu (募) points of the related zang-fu (脏腑) organs and acupoints of the foot yangming (阳明) stomach channel and foot taiyin (太阴) spleen channel. For regulating the spirit, the methods include calming the brain spirit, tranquilizing the zang organs spirit, and securing the corporeal soul gate, mainly selecting acupoints of Governer Vessel (督脉) and the back-shu (背俞) points of the corresponding zang-fu organs. Needle manipulation techniques for supplementation and drainage are flexibly applied according to the deficiency or excess nature of the syndrome. In addition, comprehensive application of moxibustion, electroacupuncture, and auricular therapy is emphasized, with the aim of providing clinical insights for diagnosis and treatment.
2.Utilization of 3D printing technology in hepatopancreatobiliary surgery
SHI WUJIANG ; WANG JIANGANG ; GAO JIANJUN ; ZOU XINLEI ; DONG QINGFU ; HUANG ZIYUE ; SHENG JIALIN ; GUAN CANGHAI ; XU YI ; CUI YUNFU ; ZHONG XIANGYU
Journal of Zhejiang University. Science. B 2024;25(2):123-134
The technology of three-dimensional(3D)printing emerged in the late 1970s and has since undergone considerable development to find numerous applications in mechanical engineering,industrial design,and biomedicine.In biomedical science,several studies have initially found that 3D printing technology can play an important role in the treatment of diseases in hepatopancreatobiliary surgery.For example,3D printing technology has been applied to create detailed anatomical models of disease organs for preoperative personalized surgical strategies,surgical simulation,intraoperative navigation,medical training,and patient education.Moreover,cancer models have been created using 3D printing technology for the research and selection of chemotherapy drugs.With the aim to clarify the development and application of 3D printing technology in hepatopancreatobiliary surgery,we introduce seven common types of 3D printing technology and review the status of research and application of 3D printing technology in the field of hepatopancreatobiliary surgery.
3.The associations of obesity phenotypes with the risk of hypertension and its transitions among middle-aged and older Chinese adults
Ziyue SHENG ; Shang LOU ; Jin CAO ; Weidi SUN ; Yaojia SHEN ; Yunhan XU ; Ziyang REN ; Wen LIU ; Qian YI ; Peige SONG
Epidemiology and Health 2023;45(1):e2023043-
OBJECTIVES:
This study aimed to investigate the associations of obesity phenotypes with hypertension stages, phenotypes, and transitions among middle-aged and older Chinese.
METHODS:
Using the 2011-2015 waves of the China Health and Retirement Longitudinal Study, we conducted a cross-sectional analysis included 9,015 subjects and a longitudinal analysis included 4,961 subjects, with 4,872 having full data on the hypertension stage and 4,784 having full data on the hypertension phenotype. Based on body mass index and waist circumstance, subjects were categorized into 4 mutually exclusive obesity phenotypes: normal weight with no central obesity (NWNCO), abnormal weight with no central obesity (AWNCO), normal weight with central obesity (NWCO), and abnormal weight with central obesity (AWCO). Hypertension stages were classified into normotension, pre-hypertension, stage 1 hypertension, and stage 2 hypertension. Hypertension phenotypes were categorized as normotension, pre-hypertension, isolated systolic hypertension (ISH), isolated diastolic hypertension (IDH), and systolic-diastolic hypertension (SDH). The association between obesity phenotypes and hypertension was estimated by logistic regression. A comparison between different sexes was conducted by testing the interaction effect of sex.
RESULTS:
NWCO was associated with normal→stage 2 (odds ratio [OR], 1.95; 95% confidence interval [CI], 1.11 to 3.42), maintained stage 1 (OR, 1.62; 95% CI, 1.14 to 2.29), and normal→ISH (OR, 1.39; 95% CI, 1.05 to 1.85). AWCO was associated with normal→stage 1 (OR, 1.75; 95% CI, 1.40 to 2.19), maintained stage 1 (OR, 2.77; 95% CI, 2.06 to 3.72), maintained stage 2 (OR, 2.80; 95% CI, 1.50 to 5.25), normal→ISH (OR, 1.56; 95% CI, 1.20 to 2.02), and normal→SDH (OR, 2.54; 95% CI, 1.72 to 3.75). An interaction effect of sex existed in the association between obesity phenotypes and hypertension stages.
CONCLUSIONS
This study highlights the importance of various obesity phenotypes and sex differences in hypertension progression. Tailored interventions for different obesity phenotypes may be warranted in hypertension management, taking into account sex-specific differences to improve outcomes.

Result Analysis
Print
Save
E-mail